Discovering up-regulated VEGF-C expression in swine umbilical vein endothelial cells by classical swine fever virus Shimen

Veterinary Research

Volumn 45, Issue 1, 2014, Pages

  Ning, Pengbo ^a   Zhang, Yanming ^a   Guo, Kangkang ^a   Chen, Ru ^a   Liang, Wulong ^a   Lin, Zhi ^a   Li, Helin ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN C;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLASSICAL SWINE FEVER; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOGENICITY; PESTIVIRUS; PHYSIOLOGY; SWINE; SWINE DISEASE; UMBILICAL VEIN; UPREGULATION; VIROLOGY; VIRULENCE;

ANIMALS; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; SWINE; SWINE DISEASES; UMBILICAL VEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VIRULENCE;

EID: 84900554723     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-45-48     Document Type: Article

References (30)

1. Classical swine fever: the global situation. Edwards S, Fukusho A, Lefevre PC, Lipowski A, Pejsak Z, Roehe P, Westergaard J, Vet Microbiol 2000 73 103 119 10.1016/S0378-1135(00)00138-3 10785321
2. Members of the let-7 family inhibit the replication of classical swine fever virus in swine umbilical vein endothelial cells. Zhang Q, Guo KK, Zhang VM, Dai C, Jiang YF, Peng YX, Asian J Anim Vet Adv 2013 8 732 739 10.3923/ajava.2013.732.739
3. Introduction to classical swine fever: virus, disease and control policy. Moennig V, Vet Microbiol 2000 73 93 102 10.1016/S0378-1135(00)00137-1 10785320
4. A promising multiple-epitope recombinant vaccine against classical swine fever virus. Tian H, Hou X, Wu J, Chen Y, Shang Y, Yin S, Zhang K, Liu X, Vet Immunol Immunopathol 2014 157 59 64 10.1016/j.vetimm.2013.10.014 24269058
5. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, Fleet C, Tritsaris K, Dissing S, Leboulch P, Cao Y, Cancer Cell 2002 1 99 108 10.1016/S1535-6108(02) 00028-4 12086892
6. Regulation of vascular permeability by vascular endothelial growth factors. Bates DO, Harper SJ, Vascul Pharmacol 2002 39 225 237 10.1016/S1537-1891(03)00011-9 12747962
7. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. Roberts WG, Palade GE, J Cell Sci 1995 108 2369 2379 7673356
8. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Monsky WL, Fukumura D, Gohongi T, Ancukiewcz M, Weich HA, Torchilin VP, Yuan F, Jain RK, Cancer Res 1999 59 4129 4135 10463618
9. VEGF receptor signalling? In control of vascular function. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L, Nat Rev Mol Cell Biol 2006 7 359 371 10.1038/nrm1911 16633338
10. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE, Cancer Res 2000 60 2898 2905 10850435
11. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K, Trends Mol Med 2011 17 347 362 10.1016/j.molmed.2011.01.015 21481637
12. VEGF: an update on biological and therapeutic aspects. Ferrara N, Curr Opin Biotechnol 2000 11 617 624 10.1016/S0958-1669(00)00153-1 11102799
13. Pathophysiological consequences of VEGF-induced vascular permeability. Weis SM, Cheresh DA, Nature 2005 437 497 504 10.1038/nature03987 16177780
14. From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis. Harry LE, Paleolog EM, Birth Defects Res C Embryo Today 2003 69 363 374 10.1002/bdrc.10024 14745976
15. Evolving functions of endothelial cells in inflammation. Pober JS, Sessa WC, Nat Rev Immunol 2007 7 803 815 10.1038/nri2171 17893694
16. Immortalization of swine umbilical vein endothelial cells with human telomerase reverse transcriptase. Hong HX, Zhang YM, Xu H, Su ZY, Sun P, Mol Cells 2007 24 358 363 18182851
17. Detection and differentiation of classical swine fever virus strains C and Shimen by high-resolution melt analysis. Ning P, Li H, Liang W, Guo K, Tan X, Cao W, Cheng L, Zhang Y, J Virol Methods 2013 194 129 131 10.1016/j.jviromet.2013.07.048 23994467
18. Judging the quality of gene expression-based clustering methods using gene annotation. Gibbons F, Roth F, Genome Res 2002 12 1574 1581 10.1101/gr.397002 12368250
19. Vascular endothelial growth factor is a secreted angiogenic mitogen. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N, Science 1989 246 1306 1309 10.1126/science.2479986 2479986
20. Systems biology of vascular endothelial growth factors. Gabhann FM, Popel AS, Microcirculation 2008 15 715 738 10.1080/10739680802095964 18608994
21. The biology of VEGF and its receptors. Ferrara N, Gerber HP, LeCouter J, Nat Med 2003 9 669 676 10.1038/nm0603-669 12778165
22. Endothelial activation and circulating markers of endothelial activation in kidney disease. Rabelink TJ, de Boer HC, van Zonneveld AJ, Nat Rev Nephrol 2010 6 404 414 10.1038/nrneph.2010.65 20498676
23. Viral vascular endothelial growth factor plays a critical role in orf virus infection. Savory LJ, Stacker SA, Fleming SB, Niven BE, Mercer AA, J Virol 2000 74 10699 10706 10.1128/JVI.74.22.10699-10706.2000 11044114
24. Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts. Wang X, Hu Q, Mansoor A, Lee J, Wang Z, Lee T, From AH, Zhang J, Am J Physiol Heart Circ Physiol 2006 290 1393 H1405 16387794
25. Up-regulation of integrin beta3 expression in porcine vascular endothelial cells cultured in vitro by classical swine fever virus. Tang QH, Zhang YM, Xu YZ, He L, Dai C, Sun P, Vet Immunol Immunopathol 2010 133 237 242 10.1016/j.vetimm.2009.07.005 19767110
26. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. Saaristo A, Veikkola T, Enholm B, Hytönen M, Arola J, Pajusola K, Turunen P, Jeltsch M, Karkkainen M, Kerjaschki D, Bueler H, Ylä-Herttuala S, Alitalo K K, FASEB J 2002 16 1041 1049 10.1096/fj.01-1042com 12087065
27. Detection of lymphangiogenesis by nearinfrared fluorescence imaging and responses to VEGFC during healing in a mouse fulldermis thickness wound model. Hall MA, Robinson H, Chan W, SevickMuraca EM, Wound Repair Regen 2013 21 604 615 10.1111/wrr.12063 23758174
28. Lymphatic vascular response to acute inflammation. Lachance PA, Hazen A, Sevick-Muraca EM, PloS One 2013 8 76078 10.1371/journal.pone.0076078 24086691
29. Clinical signs and epidemiology of classical swine fever. A review of new knowledge. Moennig V, Floegel-Niesmann G, Greiser-Wilke I, Vet J 2003 165 11 20 10.1016/S1090-0233(02)00112-0 12618065
30. Classical swine fever-an update. Paton DJ, Greiser-Wilke I, Res Vet Sci 2003 75 169 178 10.1016/S0034-5288(03)00076-6 13129664